40
Quality of life in ACHD M3C Academy November 22 nd , 2018 Pascal AMEDRO MD, PhD M3C Regional Center, Montpellier University Hospital, France PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, France

Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

QualityoflifeinACHD M3CAcademy

November22nd,2018

PascalAMEDROMD,PhD

M3CRegionalCenter,MontpellierUniversityHospital,FrancePhyMedExp,INSERMU1046,CNRSUMR9214,UniversityofMontpellier,France

Page 2: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Qualityoflife(QoL)

• Generalwell-beingofindividualsandsocieties• Lifesatisfaction

Page 3: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Health-relatedqualityoflife(HR-QoL)

• It’spartofaperson’soverallQoLthatrepresentsthefunctionaleffectofanillnessanditsconsequenttherapyuponapatient,asperceived– bythepatient(self-reportedHR-QoL)– and/orbyhis/herfamily(proxy-reportedHR-QoL)

Page 4: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

UsesofHR-QoLmeasurement

• Moreinclinicalresearchthaninmedicalpractice

• Recommendedindrugtrials(EMA)• Mayimprovepatient-doctorrelationship• Reliabletoassesstheeffectivenessandrelativesmeritsofdifferenttreatments

• Healthserviceevaluation• Policymaking

Page 5: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Health-relatedqualityoflife(HR-QoL)

• HR-QoL

• NonHR-QoL

• QoL

Page 6: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

HR-QoLinstruments

• Shouldincludeatleast4dimensions:– Physicalfunctioning– Psychologicalfunctioning– Socialfunctioning– Generalhealthperception

• Genericquestionnaires– SF-36https://www.rand.org/health/surveys_tools/mos/36-item-

short-form/survey-instrument.html• Specificquestionnaires– CAMPHOR

RascatiK.EssentialsofPharmacoeconomics.WoltersKluwer/Lippincott,Williams,&Wilkins.PhiladelphiaPA;2013.

Page 7: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

HR-QoLbelongsto«patient-relatedoutcomes»(PRO’s)

Chenetal.ProcAmThorSoc2008

Page 8: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2max

ACHD=CHF

Amedroetal.CardiolYoung2017

Page 9: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2max

CPETinACHDfollow-up

Baumgartneretal.EurHeartJ2010Amedroetal.IntJCardiol2017Marcadetetal.ACVD2018

Page 10: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2maxUnclear

Amedroetal.PedCardiol2015Jacksonetal.IntJCardiol2016

Page 11: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2max

≥1cardiacdrug

Jacksonetal.IntJCardiol2016

Page 12: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2max

28%sexualdysfunctioninACHD

Huangetal.CurrCardiolRep.2018

Page 13: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2max 4000ACHDpatients

15countries

Moonsetal.IntJCardiol2019

Page 14: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAge

Gender

Family

CHDseverity

VO2max

Income≤$30,000

Jacksonetal.IntJCardiol2016

Page 15: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthGender

Family

CHDseverity

VO2max

YesinnonsevereCHD

(male<female)

Amedroetal.PedCardiol2015

Page 16: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthGender

Family

CHDseverity

VO2max

MuchlessinsevereCHD

(male=female)

Amedroetal.CardiolYoung2017

Page 17: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAge

Family

CHDseverity

VO2max

Children>Teens>Youngadults>

Adults

Amedroetal.PedCardiol2015

Page 18: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ComponentsofQoLinACHD

QoL

NYHA

Drugs

Sexuality

SpiritualityReligion

WealthAgeGender

Family

CHDseverity

VO2maxSiblings,anxiety,depression,mourning

Amedroetal.CardiolYoung2017Eatonetal.CardiolYoung2017Yu-mietal.QualLifeOutcomes2018

Page 19: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

IsHR-QoLapredictorofmortality?

• InPAH-CHDpatients:decreaseinSF36afterinitiationofPAH-specifictherapyisapredictorofmortality

Blocketal.NethHeartJ2015

Mostimportantdeterminantsofsurvival:-HRdecreaseSF-36(PCS)=3.4-HRNYHA=4.5

YES!

Page 20: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Survival

NYHA

QoL

Page 21: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

DoesHR-QoLcorrelatewithNYHAinACHDusinggenericinstruments?

Amedroetal.CardiolYoung2016

YES!

Page 22: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

DoesHR-QoLcorrelatewithNYHAinACHDusingspecificinstruments?

Amedroetal.CardiolYoung2016

YES!

Page 23: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

QoLandphysicalcapacity

ConceptofWOOD(WHO1980)

AfunctionaltestduringexercisebetterreflectsQoLrelatedtoa

chronicdiseasethananyevaluationatrest

P.H. Wood, Appreciating the consequences of disease: the international classification ofimpairments,disabilities,andhandicaps,WHOChronicle.34(1980)

Page 24: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Survival

VO2max

QoL

Page 25: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

DoesQoLcorrelatewithphysicalcapacityinCHD?

• CorrelationbetweenQoLandVO2max– Inchronicheartfailure1,2– InACHDpatients3,4– InpediatricCHDpatients5

• CPETrecommendedinACHDfollow-up6– VO2max– VE/VCO2slope

• AndnowinpediatricCHDfollow-up7,8

YES!

1Myersetal.AmHeartJ20082Mancinietal.Circulation19913Hageretal.Heart20054Giardinietal.AnnThoracSurg20085Amedroetal.IntJCardiol20166Baumgartneretal.EurHeartJ20107Amedroetal.Heart20178Marcadetetal.ArchCardiovascDis2018

Page 26: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

QoLandphysicalactivity

• RegularphysicalactivityinACHDimprovesQoL1– Inthephysicaldimension– Andinthementalwell-being

• RegardlessACHDseverity,surgery,age,betablockers,pacemaker,SpO2

• CardiacrehabilitationinACHDpatientsshouldbepromoted2– safe– improvesVO2max

– probablyimprovesQoL31Hageretal.Heart20172Amedroetal.PressMed20173Amedroetal.IntJCardiol2019

Page 27: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

QoLandCHDseverity

• DependsontheclassificationofCHDseverity• Mostlyyes–Whenusingsimpleclassification(Bethesda)– AndforthephysicaldimensionofHR-QoL

• Nodatawithexhaustiveclassifications– ACC-CHD

Remainsunclear

Page 28: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ACC-CHDClassification

Amedroetal.Heart2017

Page 29: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ICD-10classification

Kempnyetal.EurHeartJ2012

Page 30: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Survival

CHDseverity

QoL

Page 31: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

DoesQoLcorrelatewithCHDseverity?

• PhysicaldimensionofHR-QoLimpairedinsevereCHD(Fontan,Mustard,Senning)1

• PhysicaldimensionofHR-QoLmoreimpairedinsimpleTGAthancomplexTGV2

1Kamphuisetal.Heart20022Culbertetal.Circulation2003

MostlyYESinthephysicaldimension!

Page 32: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

DoesQoLcorrelatewithCHDseverity?

Amedroetal.CardiolYoung2017

Notalwaysinthementaldimension

InACHD

Page 33: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

DoesQoLcorrelatewithCHDseverity?

Amedroetal.PedCardiol2015

Notalwaysinthementaldimension

InchildrenwithCHD

Page 34: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

GoodQoLlevelsinsevereCHD• Medicaladvances– Newtechniques(catheterization)

– Betterpatient’sglobalhealthcare

– Patienttherapeuticeducationprograms(transition)1

• AustralianACHDpatients:meanscore902

• CopinginCHDpatients2-4– Disabilityparadox– Responseshift– Senseofcoherence

1Sableetal.Circulation20112Eatonetal.CardiolYoung20173Moonsetal.EurJCardiovascNurs.20134Amedroetal.PedCardiol2015

Page 35: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ImpairedQoLinnon-severeCHD

Amedroetal.PedCardiol2015

Page 36: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

ImpairedQoLinnon-severeCHD

• Lackofautonomy1

• Patientsonthe«sideline»fromchildhood1

• Parentalbarrierstophysicalactivity2

• MusculardeconditioningandimpairedVO2maxeveninsimpleCHD(ASD,VSD)– InACHD3– Inteenagers4

1Amedroetal.PedCardiol20152Moolaetal.QualHealthRes20113Kempnyetal.EurHeartJ20124Amedroetal.Heart2018

Page 37: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

QoLinter-countryvariationinACHD

Moonsetal.IntJCardiol2018

Page 38: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

PredictorsofQoLinACHDworldwide

• Independentpatient-relatedfactors:– Functionalclass– Unemploymentstatus

• Otherfactors:– Standardofliving(grossdomesticproductspercapitaandhumandevelopmentindex)

– Healthcaresystemcharacteristics(totalhealthexpenditurepercapitaandoverallhealthsystemperformance)

Moonsetal.IntJCardiol2018

Page 39: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Remainingquestions&projects

• PredictorsofHR-QoLduringprenataldiagnosis• QoLandtype/severityofCHD– Anatomy– Physiology– CombinedCHDlesions– Invasivetreatment:surgery,cardiaccatheterization

• CompositescoresincludingQoLassessmentinclinicaltrials

• UndeterminedcomponantsofHR-QoLinCHD• RandomizedtrialswithQoLasprimaryoutcome– Qualirehab– Transition

Page 40: Quality of life in ACHDRascati K. Essentials of Pharmacoeconomics. Wolters Kluwer/Lippincott, Williams, & Wilkins. Philadelphia PA; 2013. HR-QoL belongs to « patient-related outcomes

Whatdoesmyqualityoflifecorrelatewith?